[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pavmed Inc (PAVM)

Pavmed Inc (PAVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,329
  • Shares Outstanding, K 996
  • Annual Sales, $ 70 K
  • Annual Income, $ 400 K
  • EBIT $ -22 M
  • EBITDA $ -22 M
  • 60-Month Beta 0.81
  • Price/Sales 128.24
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 0.00% (unch)
  • Historical Volatility 61.12%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Expected Move (DTE 0) 0.04 (0.58%)
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A
  • Expected Range 7.29 to 7.37

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.80
  • Number of Estimates 1
  • High Estimate $-0.80
  • Low Estimate $-0.80
  • Prior Year $-4.20
  • Growth Rate Est. (year over year) +80.95%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.51 +7.73%
on 03/27/26
10.24 -10.45%
on 04/01/26
-0.66 (-6.71%)
since 03/23/26
3-Month
7.47 +22.76%
on 01/29/26
12.50 -26.64%
on 02/02/26
+0.01 (+0.11%)
since 01/23/26
52-Week
6.00 +52.83%
on 01/02/26
28.44 -67.76%
on 01/21/26
-13.93 (-60.30%)
since 04/23/25

Most Recent Stories

More News
Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock

NEW YORK , April 23, 2026 /PRNewswire/ -- Lucid Diagnostics Inc.  (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary...

LUCD : 1.0900 (-16.79%)
PAVM : 9.17 (-2.13%)
Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference

NEW YORK , April 9, 2026 /PRNewswire/ --  Lucid Diagnostics Inc.   (Nasdaq: LUCD)  ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company...

LUCD : 1.0900 (-16.79%)
PAVM : 9.17 (-2.13%)
PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio

Medtech industry veteran to oversee development and commercialization of PAVmed's current and future medical device portfolio.

LUCD : 1.0900 (-16.79%)
PAVM : 9.17 (-2.13%)
PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

PAVmed strengthened its capital structure and relaunched its medical device portfolio under new leadership

LUCD : 1.0900 (-16.79%)
PAVM : 9.17 (-2.13%)
Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

Processed 3,664 EsoGuard ® tests and recognized 4Q25 revenue of $1.5 million

LUCD : 1.0900 (-16.79%)
PAVM : 9.17 (-2.13%)
PAVmed to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 30, 2026

Conference Call and Webcast at 8:30 AM ET

PAVM : 9.17 (-2.13%)
Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026

Conference Call and Webcast at 8:30 AM ET

LUCD : 1.0900 (-16.79%)
PAVM : 9.17 (-2.13%)
PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities

Series D Preferred Stock offering yielded $30 million of gross proceeds and includes warrants exercisable for up to an additional $30 million upon publication of a positive draft EsoGuard Medicare local...

LUCD : 1.0900 (-16.79%)
PAVM : 9.17 (-2.13%)
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®

NEW YORK , Jan. 21, 2026 /PRNewswire/ -- Lucid Diagnostics Inc.  (Nasdaq: LUCD)  ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics...

LUCD : 1.0900 (-16.79%)
PAVM : 9.17 (-2.13%)
PAVmed Announces Reverse Stock Split

NEW YORK , Dec. 30, 2025 /PRNewswire/ --  PAVmed Inc.  (NASDAQ: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical...

LUCD : 1.0900 (-16.79%)
PAVM : 9.17 (-2.13%)

Business Summary

PAVmed Inc. is a medical device company. Its diversified pipeline of products address unmet clinical needs, which consists of CarpX (TM) to treat carpal tunnel syndrome; NextFlo(TM) and NextCath(TM) a disposable infusion pump; PortIO(TM) and NextCath interventional radiology and Caldus (TM) tissue ablation...

See More

Key Turning Points

3rd Resistance Point 9.68
2nd Resistance Point 9.53
1st Resistance Point 9.45
Last Price 9.17
1st Support Level 9.22
2nd Support Level 9.07
3rd Support Level 8.99

See More

52-Week High 28.44
Fibonacci 61.8% 19.87
Fibonacci 50% 17.22
Fibonacci 38.2% 14.57
Last Price 9.17
52-Week Low 6.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.